home / stock / dtc / dtc news

DTC News and Press, Solo Brands Inc. Class A From 05/11/23

Stock Information
Company Name: Solo Brands Inc. Class A
Stock Symbol: DTC
Market: NYSE
Website: solostove.com
Menu
DTC DTC Quote DTC Short DTC News DTC Articles DTC Message Board
Get DTC Alerts

News, Short Squeeze, Breakout and More Instantly...
DTC - Solo Brands, Inc. Announces Secondary Offering of Class A Common Stock

Solo Brands, Inc. (NYSE: DTC) (“Solo Brands” or the “Company”), an omni-channel platform of beloved brands Solo Stove, Chubbies, Oru Kayak, and ISLE, today announced that certain selling stockholders of Solo Brands intend to offer 11,304,348 shares of Solo Brandsȁ...
DTC - eCommerce Penetration of Direct-to-Consumer Marketplace Reaching into the Trillions in Revenues

2023-05-04 09:00:04 ET Palm Beach, FL – May 4, 2023 – FinancialNewsMedia.com News Commentary: The global e-commerce market has shown substantial growth in the past years and is projected to continue for the next several years. Grandview Research projected that ...

DTC - Solo Brands Non-GAAP EPS of $0.16 beats by $0.10, revenue of $88.21M beats by $2.18M

2023-05-04 06:54:27 ET Solo Brands press release ( NYSE: DTC ): Q1 Non-GAAP EPS of $0.16 beats by $0.10 . Revenue of $88.21M (+7.3% Y/Y) beats by $2.18M . Reaffirming 2023 Guidance: Total revenue is expected to be between $520 million to $540 million for 20...

DTC - Solo Brands Delivers Strong First Quarter Results

Reaffirms Full Year 2023 Guidance Solo Brands, Inc. (NYSE: DTC) (“Solo Brands” or “the Company”) today announced its financial results for the three month period ended March 31, 2023. First Quarter 2023 Highlights Compared to First Quarter 2022 ...
DTC - Defence's Successful AccuTOX(TM) Pre-Clinical Efficacy Study Complete Ready For Phase I IND Filing

Vancouver, British Columbia--(Newsfile Corp. - May 2, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies is pleas...

DTC - USPTO Grants Trademark Registration for Defence Therapeutics(R)

Vancouver, British Columbia--(Newsfile Corp. - April 27, 2023) - Defence Therapeutics Inc. (CSE: DTC) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is pleased to announce that the United States Pate...

DTC - Defence Granted US Patent with Broad Coverage on Accum(TM)-based Vaccine Enhancer Platform Technology

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies including Antibod...
DTC - Solo Brands, Inc. First Quarter Fiscal 2023 Financial Results To Be Released Thursday, May 4, 2023

Solo Brands, Inc (NYSE: DTC), ("Solo Brands" or the "Company"), an omni-channel platform of beloved brands Solo Stove , Chubbies , Oru Kayak , and ISLE , today announced that it plans to report its first quarter fiscal 2023 financial results on Thursday, May 4, 2023, before the ma...

DTC - Defence's Novel Accum(TM)-mRNA Vaccine Now Administered for Testing on Cancer

Vancouver, British Columbia--(Newsfile Corp. - April 17, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is p...

DTC - RETRANSMISSION: Defence Breakthrough: Successfully Engineered Accum(TM)-mRNA Vaccine Creating a New Vaccine Platform. The in vivo Accum(TM)-mRNA Cancer Vaccine Program Begins

Vancouver, British Columbia--(Newsfile Corp. - April 11, 2023) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (" Defence " or the " Company "), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is p...
Previous 10 Next 10